Beta-adrenergic receptor blockade attenuates the exercise-induced suppression of TNF-alpha in response to lipopolysaccharide in rats

NeuroImmunoModulation

Volumn 14, Issue 2, 2007, Pages 91-96

  Kitamura, Hiromi ^a   Shiva, Daisuke ^b   Woods, Jeffrey A ^c   Yano, Hiromi ^b  

^a WAYO WOMEN'S UNIVERSITY   (Japan)

^b KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Atenolol; Catecholamine; Glucocorticoid; Propranolol

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR ANTAGONIST; LIPOPOLYSACCHARIDE; MIFEPRISTONE; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXERCISE; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SITTING; TREADMILL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CATECHOLAMINES; CORTICOSTERONE; FEMALE; LIPOPOLYSACCHARIDES; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, INBRED F344; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548864095     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107424     Document Type: Article

References (26)

1. Ortega E: Neuroendocrine mediators in the modulation of phagocytosis by exercise: physiological implications. Exerc Immunol Rev 2003;9:70-93.
2. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE: Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-1208.
3. Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002;966:290-303.
4. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-394.
5. Ignatowski TA, Spengler RN: Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J Neuroimmunol 1995;61:61-70.
6. Nieman DC: Immune response to heavy exertion. J Appl Physiol 1997;82:1385-1394.
7. Woods JA, Davis JM, Mayer EP, Ghaffar A, Pate RR: Effects of exercise on macrophage activation for antitumor cytotoxicity. J Appl Physiol 1994;76:2177-2185.
8. Sellers TL, Jaussi AW, Yang HT, Heninger RW, Winder WW: Effect of the exercise-induced increase in glucocorticoids on endurance in the rat. J Appl Physiol 1988;65:173-178.
9. Scheurink AJ, Steffens AB, Bouritius H, Dreteler GH, Bruntink R, Remie R, Zaaqsma J: Adrenal and sympathetic catecholamines in exercising rats. Am J Physiol 1989;256:R155-R160.
10. Dhabhar FS, McEwen BS: Acute stress enhances while chronic stress suppresses cellmediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immunol 1997;11:286-306.
11. Covelli V, Passeri ME, Leogrande D, Jirillo E, Amati L: Drug targets in stress-related disorders. Curr Med Chem 2005;12:1801-1809.
12. Bagby GJ, Sawaya DE, Crouch LD, Shepherd RE: Prior exercise suppresses the plasma tumor necrosis factor response to bacterial lipopolysaccharide. J Appl Physiol 1994;77:1542-1547.
13. Wanebo HJ: Tumor necrosis factors. Semin Surg Oncol 1989;5:402-413.
14. Davidson JM, Rodgers CH, Smith ER, Bloch GJ: Simulation of female sex behavior in adrenalectomized rats with estrogen alone. Endocrinology 1963;82:193-195.
15. Concordet JP, Ferry A: Physiological programmed cell death in thymocytes is induced by physical stress (exercise). Am J Physiol 1993;265:C626-C629.
16. Wade ME, Herb RA, Powers SK, Criswell D: Exercise and beta-adrenergic regulation of rat cardiac myosin isoforms. J Sports Med Phys Fitness 1999;39:42-46.
17. Ohta H, Matsumoto K, Watanabe H: The interaction between central cholinergic and peripheral β-adrenergic systems on radial maze performance in rats. Brain Res 1993;662:353-356.
18. Nabors CJ, West CD, Mahaian DK, Tyler FH: Radioimmunoassay of human plasma corticosterone: method, measurement of episodic secretion and adrenal suppression and stimulation. Steroids 1994;23:363-378.
19. Yano L, Yano H, Taketa K: Portal blood flow during and after high-intensity physical exercise in rats: response of plasma endotheline-1 and catecholamine. Hepatol Res 1998;11:1-11.
20. Monastra G, Secchi EF: Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunol Lett 1993;38:127-130.
21. Joyce DA, Kloda A, Steer JH: Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression. Immunol Cell Biol 1997;75:345-350.
22. Hawes AS, Rock CS, Keogh CV, Lowry SF, Calvano SE: In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. Infect Immun 1992;60:2641-2647.
23. Tanaka KF, Kashima H, Suzuki H, Ono K, Sawada M: Existence of functional beta1- and beta2-adrenergic receptors on microglia. J Neurosci Res 2002;70:232-237.
24. Bloksma N, Hofhuis F, Benaissa-Trouw B, Willers J: Endotoxin-induced release of tumor necrosis factor and interferon in vivo is inhibited by prior adrenoceptor blockade. Cancer Immunol Immunother 1982;14:41-45.
25. Landmann R: Beta-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest 1992;22(suppl 1):30-36.
26. Pedersen BK, Ullum H: NK cell response to physical activity: possible mechanisms of action. Med Sci Sports Exerc 1994;26:140-146.